Outcome Prediction, Stratification And Novel Treatments In Individuals At Ultra High Risk Of Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
The Ultra High Risk (UHR) criteria have been developed to identify people at high risk of psychotic disorders such as schizophrenia so that treatments can be provided early to reduce risk and disability. However the some UHR people are at risk of other difficulties and disorders and others are not at risk of all. We need to improve our ability to distinguish between these groups so that treatment can be tailored according to risk, and develop new treatments that target underlying problems.
It remains unclear what the causes of schizophrenia and other psychotic disorders are and what the most effective interventions are for preventing onset of disorder in those at risk. The current research program consists of a number of interrelated studies of how psychosis develops, the most effective sequential treatments to prevent the onset of disorder in high risk young people, and testing clinical criteria to identify young people at risk of a range of serious mental illnesses.
Lipid Biology For Prediction And Prevention Of Psychotic Disorders And Persistent Depression In Young People
Funder
National Health and Medical Research Council
Funding Amount
$638,517.00
Summary
My vision for the next 5 years is to establish ?-3PUFAs as a first-line treatment for indicated prevention of psychosis and persistent depression, as an alternative to conventional antidepressants for the treatment of moderate-to-severe depressive symptoms in adolescents and to build capacity in this area by training the next generation of researchers.
Understanding Illness Trajectories And Developing Novel Therapies For Individuals With Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$640,210.00
Summary
Understanding how the psychosis impacts on the patient and family will enable better planning of services and treatment, and facilitate the introduction of new rehabilitation/therapy options for patients at first episode of psychosis and beyond.
Maps, Models And Modifiers Of Brain Changes In Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$715,210.00
Summary
Psychosis fundamentally alters one’s relationship with reality. Brain scans can map which parts of the brain are affected by psychosis, but they cannot identify the cellular processes that cause these changes. My fellowship aims to address this gap by integrating brain imaging with genetics and mathematical modelling to identify the brain circuits and molecules that impact risk for psychosis, and to develop targeted therapies to modify these dysfunctional circuits.
Neurodevelopmental Mechanisms And Early Intervention In Psychiatric Illness
Funder
National Health and Medical Research Council
Funding Amount
$652,765.00
Summary
Schizophrenia and depression are devastating mental illnesses and a huge burden to society. Drug treatments can be beneficial, but many patients are either treatment-resistant or show severe side-effects. There is an urgent need for truly novel treatment strategies which should ideally prevent symptoms. The main aim of this project is to elucidate brain mechanisms involved in schizophrenia and depression development to inform clinical research about improved preventative treatment strategies.
Scalable Interventions For Co-existing Mental Health And Substance Use Problems: Innovation, Technology And Translation
Funder
National Health and Medical Research Council
Funding Amount
$811,293.00
Summary
Mental health and substance use problems go hand in hand, yet treatment is delivered separately because staff are not trained to treat both. However, many people with mental health and substance use problems experience difficulties attending different services and counsellors. Amanda Baker is leading a team trialling new, combined counselling interventions so that the same counsellor delivers all treatment. A new healthy lifestyles approach is expected to improve outcomes.
Neurobiology Of Schizophrenia And Translation Into New Treatments
Funder
National Health and Medical Research Council
Funding Amount
$763,845.00
Summary
We need to discover novel pharmacological therapies that operate on pathways beyond DAD2R, that will be more effective and have fewer side effects. To identify such agents, we need a better understanding of the biological basis of schizophrenia.
Mental illness is the largest single cause of disability in Australia. While mental illness is increasingly recognised as a disorder of the brain, a patient’s diagnosis, treatment and prediction of course of outcome is seldom guided by the results of a biological test. My research aims to combine the power of modern brain imaging and cutting-edge bioinformatics to enable a biological approach to the problem of mental illness.
Understanding The Pathophysiology Of Schizophrenia, Major Depressive Disorder And Bipolar Disorder As A Basis For Improving Treatments
Funder
National Health and Medical Research Council
Funding Amount
$804,106.00
Summary
The Applicant seeks to understand the causes of the schizophrenia, bipolar disorder and major depressive disorder, which affect over 20% of the Australian population. This research is important as drug design, based on chemical remodelling, has not significantly advanced initial breakthroughs in treating psychiatric disorders and there is now a widespread belief that new drugs will only come from understand their causes.